# TODO — Master Task Tracker

## Status Legend
- `[ ]` NOT_STARTED
- `[/]` IN_PROGRESS
- `[x]` COMPLETE
- `[!]` BLOCKED
- `[?]` REQUIRES_REVIEW
- `[~]` COMPLETE_WITH_NOTES

---

## Stage 0 — Framework Discovery
- [x] Inspect AntiGravity framework
- [x] Inspect ag.bat CLI
- [x] Inspect available modules (core, generator, qa, plugins)
- [x] Identify reusable capabilities
- [x] Document framework inventory (`docs/framework_inventory.md`)
- [x] Document project initialization (`docs/project_initialization.md`)
- [x] Create Stage 0 checkpoint (`qa/checkpoints/stage_00_checkpoint.md`)

## Stage 1 — Project Initialization
- [x] Run ag.bat init pharmaceutical_research_portfolio
- [x] Create full directory structure (47+ directories)
- [x] Create GOALS.md
- [x] Create ARCHITECTURE.md
- [x] Create TODO.md
- [x] Create config files (project, research, analysis YAML)
- [x] Create requirements.txt, environment.yml
- [x] Create .gitignore, LICENSE, CONTRIBUTING.md, CHANGELOG.md
- [x] Create Stage 1 checkpoint (`qa/checkpoints/stage_01_checkpoint.md`)

## Stage 2 — Topic Selection
- [x] Evaluate candidate topics against 8 feasibility criteria
- [x] Select Pharmacovigilance / Semaglutide ADRs
- [x] Create `docs/research/topic_selection.md`
- [x] Create `docs/research/research_problem.md`
- [x] Create `docs/research/scope_and_limitations.md`
- [x] Create Stage 2 checkpoint (`qa/checkpoints/stage_02_checkpoint.md`)

## Stage 3 — Research Question and Foundation
- [x] Create `docs/research/research_question.md` (PICO framework)
- [x] Create `docs/research/hypothesis.md` (Null vs Alternative)
- [x] Create `docs/research/research_gaps.md`
- [x] Create `docs/research/conceptual_framework.md`
- [x] Create Stage 3 checkpoint (`qa/checkpoints/stage_03_checkpoint.md`)

## Stage 4 — Literature Search
- [x] Search PubMed for Semaglutide FAERS articles
- [x] Verify 17 scholarly articles (DOI/PMID verified against NLM)
- [x] Create 17 article summaries in `week1_literature_review/article_summaries/`
- [x] Create `week1_literature_review/literature_matrix.csv`
- [x] Create `week1_literature_review/literature_matrix.xlsx`
- [x] Create search strategy documentation (`search_strategy.md`)
- [x] Create inclusion/exclusion criteria (`inclusion_exclusion_criteria.md`)
- [x] Create Stage 4 checkpoint (`qa/checkpoints/stage_04_checkpoint.md`)

## Stage 5 — Literature Synthesis
- [x] Create emerging trends analysis (`synthesis/emerging_trends.md`)
- [x] Create breakthroughs analysis (`synthesis/breakthroughs.md`)
- [x] Create challenges analysis (`synthesis/challenges.md`)
- [x] Create research gaps synthesis (`synthesis/research_gaps.md`)
- [x] Create conceptual framework (`synthesis/conceptual_framework.md`)
- [x] Create Stage 5 checkpoint (`qa/checkpoints/stage_05_checkpoint.md`)

## Stage 6 — Week 1 Report
- [x] Generate `reports/week1/week1_literature_review.docx`
- [x] Copy to `submission/week1/week1_literature_review.docx`
- [x] Create `references/master_references.bib` and `master_references.csv`
- [x] Create 200+ word submission description (`submission/week1/week1_submission_description.md`)
- [x] Create Stage 6 checkpoint (`qa/checkpoints/stage_06_checkpoint.md`)

## Stage 7 — Dataset Discovery
- [x] Evaluate FDA FAERS as data source
- [x] Document data collection plan (`docs/methodology/data_collection_plan.md`)
- [x] Create metadata documentation (`data/metadata/source_metadata.md`, `data_dictionary.md`)
- [x] Create Stage 7 checkpoint (`qa/checkpoints/stage_07_checkpoint.md`)

## Stage 8 — Data Collection and Cleaning
- [x] Collect FAERS data via OpenFDA API (`data_collection.py`)
- [x] Preserve raw data in `data/raw/raw_faers_data.csv`
- [x] Clean and process data (`data_cleaning.py`)
- [x] Create `week2_data_analysis/dataset/pharmaceutical_dataset.csv` and `.xlsx`
- [x] Create Stage 8 checkpoint (`qa/checkpoints/stage_08_checkpoint.md`)

## Stage 9 — Statistical Analysis
- [x] Compute descriptive statistics (`descriptive_statistics.py`)
- [x] Compute disproportionality tests: ROR, PRR, Chi2 (`statistical_tests.py`)
- [x] Create 8 publication-quality figures (`visualization.py`)
- [x] Create interactive Jupyter notebook (`notebooks/pharmaceutical_data_analysis.ipynb`)
- [x] Create Stage 9 checkpoint (`qa/checkpoints/stage_09_checkpoint.md`)

## Stage 10 — Week 2 Report
- [x] Generate `reports/week2/week2_data_analysis.docx` (all 8 figures embedded)
- [x] Copy to `submission/week2/week2_data_analysis.docx`
- [x] Create 200+ word submission description (`submission/week2/week2_submission_description.md`)
- [x] Create Stage 10 checkpoint (`qa/checkpoints/stage_10_checkpoint.md`)

## Stage 11 — Experimental Design
- [x] Define research question and hypotheses for prospective active surveillance
- [x] Define variable taxonomy (independent, dependent, controls, confounders)
- [x] Formulate active comparator control strategy (SGLT2 inhibitors)
- [x] Calculate sample size and statistical power (N=2,000 cohort)
- [x] Create Stage 11 checkpoint (`qa/checkpoints/stage_11_checkpoint.md`)

## Stage 12 — Simulated Protocol
- [x] Create clinical trial experimental protocol (`experimental_protocol.md`)
- [x] Create longitudinal data collection plan (`data_collection_plan.md`)
- [x] Create statistical analysis plan (`statistical_analysis_plan.md`)
- [x] Create Stage 12 checkpoint (`qa/checkpoints/stage_12_checkpoint.md`)

## Stage 13 — Safety, Ethics, and Troubleshooting
- [x] Create safety protocol & electronic crisis alert escalation (`safety_protocol.md`)
- [x] Create ethical considerations & DSMB stopping rules (`ethical_considerations.md`)
- [x] Create troubleshooting and risk mitigation matrix (`troubleshooting.md`)
- [x] Create Stage 13 checkpoint (`qa/checkpoints/stage_13_checkpoint.md`)

## Stage 14 — Week 3 Report
- [x] Programmatically render study workflow diagram (`assets/figures/week3_study_flowchart.png`)
- [x] Generate `reports/week3/week3_experimental_design.docx`
- [x] Copy to `submission/week3/week3_experimental_design.docx`
- [x] Create 200+ word submission description (`submission/week3/week3_submission_description.md`)
- [x] Create Stage 14 checkpoint (`qa/checkpoints/stage_14_checkpoint.md`)

## Stage 15 — Article Selection
- [x] Select landmark STEP 1 trial (Wilding et al., 2021, NEJM)
- [x] Extract and verify complete bibliographic and demographic metadata
- [x] Create `week4_critical_evaluation/selected_article.md` & `article_metadata.md`
- [x] Create Stage 15 checkpoint (`qa/checkpoints/stage_15_checkpoint.md`)

## Stage 16 — Methodological Critique
- [x] Appraise trial against CONSORT 2010 and ICH-E6 GCP guidelines
- [x] Analyze strengths (randomization, estimands, retention)
- [x] Diagnose safety blindspots (psychiatric exclusion, passive adverse event capture)
- [x] Formulate actionable recommendations for next-generation trials
- [x] Create Stage 16 checkpoint (`qa/checkpoints/stage_16_checkpoint.md`)

## Stage 17 — Week 4 Report
- [x] Generate `week4_critical_evaluation/methodology_matrix.csv` and `.xlsx`
- [x] Generate `reports/week4/week4_critical_evaluation.docx`
- [x] Copy to `submission/week4/week4_critical_evaluation.docx`
- [x] Create 200+ word submission description (`submission/week4/week4_submission_description.md`)
- [x] Create Stage 17 checkpoint (`qa/checkpoints/stage_17_checkpoint.md`)

## Stage 18 — Cross-Week Integration
- [x] Verify scientific lineage across all four weekly modules
- [x] Audit terminology, hypotheses, and numerical data consistency
- [x] Create `docs/integration_map.md`
- [x] Create Stage 18 checkpoint (`qa/checkpoints/stage_18_checkpoint.md`)

## Stage 19 — Master Reference Audit
- [x] Audit 17 primary sources; confirm 0 hallucinations, 100% APA 7th compliance
- [x] Verify `references/master_references.bib` and `master_references.csv`
- [x] Create `qa/citation_validation.md`
- [x] Create Stage 19 checkpoint (`qa/checkpoints/stage_19_checkpoint.md`)

## Stage 20 — Statistical and Data Audit
- [x] Independently verify end-to-end analytical data pipeline
- [x] Re-calculate all contingency tables, ROR, CI, PRR, Chi2; confirm 0 discrepancies
- [x] Create `qa/statistical_validation.md`
- [x] Create Stage 20 checkpoint (`qa/checkpoints/stage_20_checkpoint.md`)

## Stage 21 — Document QA
- [x] Inspect all Word documents for formatting, typography, tables, and figures
- [x] Programmatically verify 0 occurrences of placeholder text
- [x] Create `qa/document_validation.md`
- [x] Create Stage 21 checkpoint (`qa/checkpoints/stage_21_checkpoint.md`)

## Stage 22 — Academic Integrity Audit
- [x] Confirm data authenticity, simulation transparency, and ethical compliance
- [x] Create `qa/research_quality_checklist.md`
- [x] Create Stage 22 checkpoint (`qa/checkpoints/stage_22_checkpoint.md`)

## Stage 23 — Final Portfolio Generation
- [x] Synthesize entire 4-week investigation into master integrated Word report
- [x] Generate `reports/final/final_integrated_research_portfolio.docx`
- [x] Copy to `submission/final_portfolio/final_integrated_research_portfolio.docx`
- [x] Create Stage 23 checkpoint (`qa/checkpoints/stage_23_checkpoint.md`)

## Stage 24 — Submission Package
- [x] Populate clean modular directories in `submission/`
- [x] Verify all 5 submission descriptions >= 200 words
- [x] Create Stage 24 checkpoint (`qa/checkpoints/stage_24_checkpoint.md`)

## Stage 25 — AntiGravity Validation
- [x] Run `ag.bat validate` (passed all framework gates)
- [x] Run automated project QA runner (`src/qa_runner.py`) (passed all 6 gates)
- [x] Create Stage 25 checkpoint (`qa/checkpoints/stage_25_checkpoint.md`)

## Stage 26 — Final Audit and Status Signoff
- [x] Create `qa/final_audit.md`
- [x] Create `FINAL_STATUS.md`
- [x] Create Stage 26 checkpoint (`qa/checkpoints/stage_26_checkpoint.md`)
- [x] Update `TODO.md` and `CHANGELOG.md`
- [x] Update project `README.md`
